Protein Adsorption: A Feasible Method for Nanoparticle Functionalization?
drug delivery
nanoparticles
protein corona
surface functionalization
Journal
Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929
Informations de publication
Date de publication:
21 Jun 2019
21 Jun 2019
Historique:
received:
01
06
2019
revised:
18
06
2019
accepted:
20
06
2019
entrez:
26
6
2019
pubmed:
27
6
2019
medline:
27
6
2019
Statut:
epublish
Résumé
Nanomaterials are now well-established components of many sectors of science and technology. Their sizes, structures, and chemical properties allow for the exploration of a vast range of potential applications and novel approaches in basic research. Biomedical applications, such as drug or gene delivery, often require the release of nanoparticles into the bloodstream, which is populated by blood cells and a plethora of small peptides, proteins, sugars, lipids, and complexes of all these molecules. Generally, in biological fluids, a nanoparticle's surface is covered by different biomolecules, which regulate the interactions of nanoparticles with tissues and, eventually, their fate. The adsorption of molecules onto the nanomaterial is described as "corona" formation. Every blood particulate component can contribute to the creation of the corona, although small proteins represent the majority of the adsorbed chemical moieties. The precise rules of surface-protein adsorption remain unknown, although the surface charge and topography of the nanoparticle seem to discriminate the different coronas. We will describe examples of adsorption of specific biomolecules onto nanoparticles as one of the methods for natural surface functionalization, and highlight advantages and limitations. Our critical review of these topics may help to design appropriate nanomaterials for specific drug delivery.
Identifiants
pubmed: 31234290
pii: ma12121991
doi: 10.3390/ma12121991
pmc: PMC6632036
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Pharm Res. 1999 Oct;16(10):1564-9
pubmed: 10554098
Colloids Surf B Biointerfaces. 2000 Oct 1;18(3-4):301-313
pubmed: 10915952
J Drug Target. 2002 Jun;10(4):317-25
pubmed: 12164380
Eur J Pharm Biopharm. 2002 Sep;54(2):165-70
pubmed: 12191688
J Biomed Mater Res A. 2003 Jun 1;65(3):319-26
pubmed: 12746878
J Control Release. 2004 Dec 10;100(3):451-5
pubmed: 15567509
J Drug Target. 2005 Apr;13(3):179-87
pubmed: 16036306
Drug Discov Today. 2005 Nov 1;10(21):1451-8
pubmed: 16243265
Int J Pharm. 2006 Jan 3;307(1):93-102
pubmed: 16303268
Int J Pharm. 2007 Feb 1;329(1-2):110-6
pubmed: 17000067
Cell Mol Life Sci. 2007 Feb;64(3):356-64
pubmed: 17256088
Tumori. 2008 Mar-Apr;94(2):271-7
pubmed: 18564616
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70
pubmed: 18809927
Nanomedicine. 2009 Jun;5(2):106-17
pubmed: 19071065
Adv Drug Deliv Rev. 2009 Jun 21;61(6):428-37
pubmed: 19376175
Nanotechnology. 2009 Nov 11;20(45):455101
pubmed: 19822937
Small. 2010 Jan;6(1):12-21
pubmed: 19844908
PLoS One. 2010 Jul 29;5(7):e11862
pubmed: 20686681
Expert Opin Drug Deliv. 2011 Mar;8(3):343-57
pubmed: 21291354
Toxicol Lett. 2012 Jan 5;208(1):41-50
pubmed: 22001751
ACS Nano. 2012 Mar 27;6(3):2532-41
pubmed: 22356488
Nat Nanotechnol. 2012 Dec;7(12):779-86
pubmed: 23212421
J Phys Chem C Nanomater Interfaces. 2012 Oct 18;116(41):22098-22103
pubmed: 23243478
Colloids Surf B Biointerfaces. 2013 Apr 1;104:213-20
pubmed: 23318220
Nat Nanotechnol. 2013 Feb;8(2):137-43
pubmed: 23334168
Science. 2013 Feb 22;339(6122):971-5
pubmed: 23430657
J Nanobiotechnology. 2013 Jul 19;11:26
pubmed: 23870291
Biomaterials. 2013 Nov;34(33):8521-30
pubmed: 23932500
Adv Drug Deliv Rev. 2014 May;71:2-14
pubmed: 23981489
PLoS One. 2013 Sep 09;8(9):e74001
pubmed: 24040142
ACS Appl Mater Interfaces. 2013 Dec 26;5(24):13171-9
pubmed: 24245615
Expert Opin Drug Deliv. 2014 Mar;11(3):409-20
pubmed: 24397260
Nanoscale. 2014 Mar 7;6(5):2782-92
pubmed: 24463404
J R Soc Interface. 2014 Feb 26;11(94):20130818
pubmed: 24573329
Colloids Surf B Biointerfaces. 2014 Dec 1;124:17-24
pubmed: 24656615
Nanomedicine. 2015 Apr;11(3):543-57
pubmed: 25555353
Biomacromolecules. 2015 Apr 13;16(4):1311-21
pubmed: 25794196
Angew Chem Int Ed Engl. 2015 Jun 15;54(25):7436-40
pubmed: 25940402
Nanoscale Res Lett. 2015 May 16;10:221
pubmed: 25995715
Carbohydr Polym. 2015 Sep 20;129:25-34
pubmed: 26050884
ACS Nano. 2015 Jul 28;9(7):6996-7008
pubmed: 26079146
Biomaterials. 2016 Jan;75:295-304
pubmed: 26513421
Nat Nanotechnol. 2016 Apr;11(4):372-7
pubmed: 26878141
Bioconjug Chem. 2017 Feb 15;28(2):471-480
pubmed: 27977155
Biochem Biophys Res Commun. 2016 Nov 25;480(4):690-695
pubmed: 27983983
Nat Nanotechnol. 2017 May;12(4):387-393
pubmed: 27992410
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Nov;9(6):
pubmed: 28296346
Nat Nanotechnol. 2017 Apr 6;12(4):288-290
pubmed: 28383044
Int J Nanomedicine. 2017 Apr 18;12:3137-3151
pubmed: 28458536
Nano Today. 2017 Aug;15:8-10
pubmed: 29399037
ACS Nano. 2018 Jun 26;12(6):5834-5847
pubmed: 29750504
Nanoscale. 2018 Jun 14;10(22):10731-10739
pubmed: 29845991
Colloids Surf B Biointerfaces. 2018 Oct 1;170:179-186
pubmed: 29906703
Nat Nanotechnol. 2018 Sep;13(9):862-869
pubmed: 29915272
J Nanosci Nanotechnol. 2018 Oct 1;18(10):6653-6670
pubmed: 29954482
Molecules. 2018 Jul 12;23(7):null
pubmed: 30002298
Nanomaterials (Basel). 2018 Sep 22;8(10):null
pubmed: 30248990
J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1533-1540.e8
pubmed: 30557713
Nat Nanotechnol. 2019 Mar;14(3):260-268
pubmed: 30643271
Pharmaceutics. 2019 Jan 15;11(1):null
pubmed: 30650541
Pharm Res. 1996 Jul;13(7):1055-8
pubmed: 8842044
J Microencapsul. 1998 Jan-Feb;15(1):67-74
pubmed: 9463808